| Basics |
Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
|
| IPO Date: |
November 9, 1984 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$321.26M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.19 | 3.63%
|
| Avg Daily Range (30 D): |
$0.23 | 3.99%
|
| Avg Daily Range (90 D): |
$0.18 | 3.28%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.75M |
| Avg Daily Volume (30 D): |
2.37M |
| Avg Daily Volume (90 D): |
1.15M |
| Trade Size |
| Avg Trade Size (Sh.): |
230 |
| Avg Trade Size (Sh.) (30 D): |
144 |
| Avg Trade Size (Sh.) (90 D): |
136 |
| Institutional Trades |
| Total Inst.Trades: |
372 |
| Avg Inst. Trade: |
$1.4M |
| Avg Inst. Trade (30 D): |
$.9M |
| Avg Inst. Trade (90 D): |
$.88M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.68M |
| Avg Closing Trade (30 D): |
$.97M |
| Avg Closing Trade (90 D): |
$.97M |
| Avg Closing Volume: |
19.56K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.82
|
$-.24
|
$-.14
|
|
Diluted EPS
|
$-1.27
|
$-.24
|
$-.14
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -44.19M
|
$ -12.03M
|
$ -9.29M
|
|
Operating Income / Loss
|
$ -69.61M
|
$ -19.73M
|
$ -16.67M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -1.62M
|
$ -7.42M
|
$ 7.63M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 05, 2022:
1:25
|
|
Oct 24, 2014:
1:50
|
|
Jun 05, 2006:
1:5
|
|
|
|
